Obstet Gynecol Sci.  2019 Jul;62(4):233-241. 10.5468/ogs.2019.62.4.233.

Is preeclampsia itself a risk factor for the development of metabolic syndrome after delivery?

Affiliations
  • 1Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Korea. mjohmd@korea.ac.kr
  • 2Department of Obstetrics and Gynecology, Hanyang University Guri Hospital, College of Medicine, Hanyang University, Guri, Korea.
  • 3Big Data Steering Department, National Health Insurance Service, Wonju, Korea.

Abstract


OBJECTIVE
This study aimed to determine the association between preeclampsia and the postpartum development of metabolic syndrome based on the pre-pregnancy status.
METHODS
Korean women who delivered their first child between January 1, 2011, and December 31, 2012, were enrolled. All subjects underwent a national health screening examination conducted by the National Health Insurance Corporation 1 or 2 years prior to their first delivery and within 2 years after their first delivery.
RESULTS
Among the 49,065 participants, preeclampsia developed in 3,391 participants (6.9%). The prevalence of metabolic syndrome was higher postpartum in women with preeclampsia than in those without preeclampsia (4.9% vs. 2.7%, respectively, P<0.001). Through the pre-pregnancy to postpartum period, women with preeclampsia had a greater increase in gestational weight retention, body mass index, waist circumference, systolic blood pressure, and triglyceride levels and a greater decrease in high-density lipoprotein cholesterol levels than women without preeclampsia. Preeclampsia was associated with an increased risk of the postpartum development of metabolic syndrome in women without pre-pregnancy metabolic syndrome (odds ratio, 1.28; 95% confidence interval, 1.05-1.56). However, preeclampsia was not associated with postpartum metabolic syndrome in women with pre-pregnancy metabolic syndrome or 2 components of metabolic syndrome.
CONCLUSION
In this study, preeclampsia was associated with the postpartum development of metabolic syndrome in women without pre-pregnancy metabolic syndrome. However, the effects were attenuated by predisposing risk factors in the pre-pregnancy period.

Keyword

Preeclampsia; Metabolic syndrome; Cardiovascular disease; Diabetes mellitus; Hypertension

MeSH Terms

Blood Pressure
Body Mass Index
Cardiovascular Diseases
Child
Cholesterol
Diabetes Mellitus
Female
Humans
Hypertension
Lipoproteins
Mass Screening
National Health Programs
Postpartum Period
Pre-Eclampsia*
Prevalence
Risk Factors*
Triglycerides
Waist Circumference
Cholesterol
Lipoproteins

Reference

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009; 33:130–137.
Article
2. Koonin LM, MacKay AP, Berg CJ, Atrash HK, Smith JC. Pregnancy-related mortality surveillance--United States, 1987–1990. MMWR CDC Surveill Summ. 1997; 46:17–36.
3. Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for preeclampsia prevention study group. Obstet Gynecol. 2000; 95:24–28.
4. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart. 1997; 77:154–158.
Article
5. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003; 326:845.
Article
6. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001; 357:2002–2006.
Article
7. Feig DS, Shah BR, Lipscombe LL, Wu CF, Ray JG, Lowe J, et al. Preeclampsia as a risk factor for diabetes: a population-based cohort study. PLoS Med. 2013; 10:e1001425.
Article
8. American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy. Obstet Gynecol. 2013; 122:1122–1131.
9. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004; 109:42–46.
Article
10. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28:1769–1778.
Article
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285:2486–2497.
12. Pouta A, Hartikainen AL, Sovio U, Gissler M, Laitinen J, McCarthy MI, et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension. 2004; 43:825–831.
Article
13. Forest JC, Girouard J, Massé J, Moutquin JM, Kharfi A, Ness RB, et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol. 2005; 105:1373–1380.
Article
14. Yang JJ, Lee SA, Choi JY, Song M, Han S, Yoon HS, et al. Subsequent risk of metabolic syndrome in women with a history of preeclampsia: data from the health examinees study. J Epidemiol. 2015; 25:281–288.
Article
15. Smith GN, Pudwell J, Walker M, Wen SW. Risk estimation of metabolic syndrome at one and three years after a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can. 2012; 34:836–841.
Article
16. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007; 75:72–80.
Article
17. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26:3160–3167.
Article
18. Smith DE, Lewis CE, Caveny JL, Perkins LL, Burke GL, Bild DE. Longitudinal changes in adiposity associated with pregnancy. The cardia study. Coronary artery risk development in young adults study. JAMA. 1994; 271:1747–1751.
Article
19. Cho GJ, Yoon HJ, Kim EJ, Oh MJ, Seo HS, Kim HJ. Postpartum changes in body composition. Obesity (Silver Spring). 2011; 19:2425–2428.
Article
20. Rönnemaa T, Koskenvuo M, Marniemi J, Koivunen T, Sajantila A, Rissanen A, et al. Glucose metabolism in identical twins discordant for obesity. The critical role of visceral fat. J Clin Endocrinol Metab. 1997; 82:383–387.
21. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord. 2004; 28:1018–1025.
Article
22. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991; 165:1667–1672.
Article
23. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol. 1979; 133:165–170.
Article
24. Alvarez JJ, Montelongo A, Iglesias A, Lasunción MA, Herrera E. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res. 1996; 37:299–308.
Article
25. Truong YN, Yee LM, Caughey AB, Cheng YW. Weight gain in pregnancy: does the Institute of Medicine have it right? Am J Obstet Gynecol. 2015; 212:362.e1–362.e8.
Article
26. Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism. 1999; 48:892–896.
Article
27. Wiznitzer A, Mayer A, Novack V, Sheiner E, Gilutz H, Malhotra A, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol. 2009; 201:482.e1–482.e8.
Article
28. Hermes W, Ket JC, van Pampus MG, Franx A, Veenendaal MV, Kolster C, et al. Biochemical cardiovascular risk factors after hypertensive pregnancy disorders: a systematic review and meta-analysis. Obstet Gynecol Surv. 2012; 67:793–809.
29. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010; 122:579–584.
30. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis. 2004; 175:189–202.
Article
31. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. Circulation. 2011; 123:1243–1262.
32. Veerbeek JH, Hermes W, Breimer AY, van Rijn BB, Koenen SV, Mol BW, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension. 2015; 65:600–606.
Article
33. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001; 323:1213–1217.
34. Schwarz EB, McClure CK, Tepper PG, Thurston R, Janssen I, Matthews KA, et al. Lactation and maternal measures of subclinical cardiovascular disease. Obstet Gynecol. 2010; 115:41–48.
Article
35. Scholten RR, Thijssen DJ, Lotgering FK, Hopman MT, Spaanderman ME. Cardiovascular effects of aerobic exercise training in formerly preeclamptic women and healthy parous control subjects. Am J Obstet Gynecol. 2014; 211:516.e1–516.e11.
Article
36. Kang HY, Lim SJ, Suh HS, Liew D. Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study. BMC Public Health. 2011; 11:646.
Article
37. Park BJ, Sung JH, Park KD, Seo SW, Kim SW. Report of the evaluation for validity of discharged diagnoses in Korean health insurance database. Seoul: Seoul National University;2003.
38. Park JK, Kim KS, Kim CB, Lee TY, Lee KS, Lee DH, et al. The accuracy of icd codes for cerebrovascular diseases in medical insurance claims. Korean J Prev Med. 2000; 33:76–82.
39. Kim JY. Strategies to enhance the use of national health insurance claims database in generating health statistics. Seoul: Health Insurance Review & Assessment Service;2005.
40. Park BJ, Sung JH, Park KD, Seo SW, Kim SW. Strategies to improve the validity of diagnostic codes of national health insurance claims data. Seoul: Health Insurance Review & Assessment Service;2002.
Full Text Links
  • OGS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr